Josef Simon, MD
Orthopaedic Surgery of the Spine · Cambridge, MANPI 1366638710
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $861 of the $1,374 with a category attached, or 62.7%. Medical Device Business Services, Inc. accounts for 92.8% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2019 at $1,207 and has fallen 98.0% since, to $24 in 2025. That places this record below the midpoint for orthopaedic surgery of the spine clinicians in MA, where the typical reported total is $21,142.
Across 18 payments — averaging $76.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medical Device Business Services, Inc.$1K
- Johnson & Johnson$25
- Pacira Therapeutics, Inc.$25
- Smith+Nephew$25
- Convatec Inc.$24
What the payments were for
- Travel & lodging$86163%
- Food & beverage$51337%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medical Device Business Services, Inc. | 14 | $1,274 |
| Johnson & Johnson | 1 | $25 |
| Pacira Therapeutics, Inc. | 1 | $25 |
| Smith+Nephew | 1 | $25 |
| Convatec Inc. | 1 | $24 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,374 in reported general payments places this provider in the 10th percentile of 28 orthopaedic surgery of the spine providers in Massachusetts.
See all orthopaedic surgery of the spine providers in Massachusetts →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 14 | $558 |
| Gabapentin | 42 | $512 |
| Oxycodone Hcl | 20 | $129 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery of the spine in Cambridge
- Paul GlazerChestnut Hill$2.1M
- Raymond HwangChestnut Hill$1.1M
- Robert BancoWellesley Hills$661K
- Mitchell HardenbrookHopedale$542K
- Steven LeckiePlymouth$316K
- Jeremy ShorePeabody$232K
- Richard OzunaPeabody$198K
- Nikhil ThakurNorth Andover$118K
- Chadi TannouryBoston$81K
- Bryce BasquesRaynham$72K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.